GHRH-Analog Mechanism Tesamorelin is structurally modified from naturally occurring GHRH to resist enzymatic degradation, giving it a longer research half-life than unmodified GHRH
Peptide therapies are used in medical settings to support metabolic function, recovery, and hormone balance
CJC-1295 Structure CAS #: 446036-97-1 Molecular Formula: CHNO Molecular Weight: 3367.9 g/mol PubChem ID: 91976842 Ipamorelin Structure CAS #: 170851-70-4 Molecular Formula: CHNO Molecular Weight: 3367.9 g/mol PubChem ID: 91976842 CJC-1295 and Ipamorelin have been examined in endocrine, metabolic, regenerative, and systemic models, with research exploring their influence on growth hormone pathways, body composition, tissue recovery, and cellular viability
reconstitute fresh vial as each is exhausted
5 Krieger, C
Our physicians carefully evaluate candidacy through comprehensive assessment